Identification and validation of a novel long non-coding RNA (LINC01465) in ovarian cancer
暂无分享,去创建一个
A. Okamoto | I. Gupta | Y. Tamimi | I. Burney | M. Al Kalbani | Shika Hanif Malgundkar | H. Al Riyami | Nada Abdullah Hassan | Hala Al Badi | Z. Al Hashami | Hamida Al Barwani | R. Lakhtakia | H. Al Barwani | S. Malgundkar
[1] K. Gomes,et al. Metformin Treatment Modulates Long Non-Coding RNA Isoforms Expression in Human Cells , 2022, Non-coding RNA.
[2] Jianghu Huang,et al. LINC00662 facilitates osteosarcoma progression via sponging miR‐103a‐3p and regulating SIK2 expression , 2021, Journal of tissue engineering and regenerative medicine.
[3] B. Zhivotovsky,et al. Long non-coding RNAs: A view to kill ovarian cancer. , 2021, Biochimica et biophysica acta. Reviews on cancer.
[4] B. Tsang,et al. Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis , 2021, Molecules.
[5] W. Wang,et al. Long Non-Coding RNA LINC00313 Accelerates Cervical Carcinoma Progression by miR-4677-3p/CDK6 Axis , 2021, OncoTargets and therapy.
[6] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[7] Yuqin Wang,et al. LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis , 2020, Cancer management and research.
[8] H. You,et al. LncRNA SOCS2-AS1 inhibits progression and metastasis of colorectal cancer through stabilizing SOCS2 and sponging miR-1264 , 2020, Aging.
[9] A. Okamoto,et al. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer , 2020, BMC Cancer.
[10] Lei Wang,et al. lncRNA MEG3 modified epithelial‐mesenchymal transition of ovarian cancer cells by sponging miR‐219a‐5p and regulating EGFR , 2019, Journal of cellular biochemistry.
[11] Enxin Zhang,et al. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue , 2019, BMC Cancer.
[12] Alireza Hadj Khodabakhshi,et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.
[13] Chen Yu,et al. Long noncoding RNA SNHG6 functions as a competing endogenous RNA by sponging miR-181a-5p to regulate E2F5 expression in colorectal cancer , 2019, Cancer management and research.
[14] Anushya Muruganujan,et al. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools , 2018, Nucleic Acids Res..
[15] Jia Hu,et al. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1 , 2018, Journal of experimental & clinical cancer research : CR.
[16] J. Peters,et al. Molecular Regulation of Carcinogenesis: Friend and Foe. , 2018, Toxicological sciences : an official journal of the Society of Toxicology.
[17] A. Jemal,et al. Ovarian cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[18] Qian Xu,et al. A comprehensive evaluation for polymorphisms in let-7 family in cancer risk and prognosis: a system review and meta-analysis , 2018, Bioscience reports.
[19] F. Dick,et al. Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family. , 2016, Journal of molecular biology.
[20] H. Tian,et al. miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells. , 2016, American journal of translational research.
[21] Yanqing Ding,et al. MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer. , 2015, Experimental and molecular pathology.
[22] Hua Tang,et al. Up-regulated MicroRNA-181a induces carcinogenesis in Hepatitis B virus-related hepatocellular carcinoma by targeting E2F5 , 2014, BMC Cancer.
[23] D. Ichikawa,et al. E2F5 as an independent prognostic factor in esophageal squamous cell carcinoma. , 2013, Anticancer research.
[24] S. Shah,et al. Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research , 2013, PloS one.
[25] C. Sander,et al. Evaluating cell lines as tumour models by comparison of genomic profiles , 2013, Nature Communications.
[26] Xin Fu,et al. Analysis of genetic aberrations on chromosomal region 8q21–24 identifies E2F5 as an oncogene with copy number gain in prostate cancer , 2013, Medical Oncology.
[27] A. Morillon,et al. Noncoding RNAs in gene regulation , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.
[28] Bei Zhang,et al. An overview of biomarkers for the ovarian cancer diagnosis. , 2011, European journal of obstetrics, gynecology, and reproductive biology.
[29] A. Chinnaiyan,et al. The emergence of lncRNAs in cancer biology. , 2011, Cancer discovery.
[30] Howard Y. Chang,et al. Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.
[31] P. Pandolfi,et al. A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.
[32] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[33] Vladimir B Bajic,et al. E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer , 2010, BMC Cancer.
[34] J. Mattick,et al. Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.
[35] C. Ponting,et al. Evolution and Functions of Long Noncoding RNAs , 2009, Cell.
[36] Joel Greshock,et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. , 2008, Cancer research.
[37] T. Volkert,et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.
[38] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[39] G. Mills,et al. Genetic analysis of early- versus late-stage ovarian tumors. , 2001, Cancer research.
[40] J. Nevins,et al. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. , 2000, Molecular cell.
[41] E. Miyagi,et al. Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties. , 1995, Gynecologic oncology.
[42] Kai Huang,et al. Non-coding RNAs as regulators in epigenetics (Review). , 2017, Oncology reports.
[43] Chandrasekhar Kanduri,et al. Long Noncoding RNA: Genome Organization and Mechanism of Action. , 2017, Advances in experimental medicine and biology.
[44] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .